Compugen Ltd. Logo

Compugen Ltd.

A clinical-stage company developing cancer immunotherapies using an AI platform.

CGEN | TA

Overview

Corporate Details

ISIN(s):
IL0010852080
LEI:
Country:
Israel
Address:
26 Harokmim St., Bldg D, 5885849 Holon

Description

Compugen Ltd. is a clinical-stage therapeutic discovery and development company specializing in cancer immunotherapy. A pioneer in its field, the company leverages a proprietary, broadly applicable, and predictive AI-powered computational discovery platform to identify novel drug targets. Its primary focus is on developing innovative, first-in-class therapeutics designed to modulate the tumor microenvironment and enhance anti-tumor immune responses. Compugen's mission is to advance its pipeline of drug candidates to address patient populations unresponsive to current immunotherapy treatments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-10 15:00
Reports Third Quarter 2025 Results
English 516.5 KB
2025-11-10 15:00
Reports Third Quarter 2025 Results
English 36.4 KB
2025-11-04 15:00
Compugen to Participate in Stifel 2025 Healthcare Conference
English 149.5 KB
2025-11-04 15:00
Compugen to Participate in Stifel 2025 Healthcare Conference
English 36.4 KB
2025-10-27 14:00
Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025
English 130.8 KB
2025-10-27 14:00
Compugen to Release Third Quarter 2025 Results on Monday, November 10, 2025
English 36.4 KB
2025-10-14 16:00
Immediate Report
English 522.6 KB
2025-10-14 16:00
Immediate Report
English 36.6 KB
2025-10-13 16:00
Other Report or Announcement
English 159.5 KB
2025-10-13 16:00
Other Report or Announcement
English 36.5 KB
2025-10-06 16:00
Other Report or Announcement
English 159.9 KB
2025-10-06 16:00
Other Report or Announcement
English 36.4 KB
2025-09-17 16:00
RESULTS OF A MEETING HELD ON AUGUEST 6, 2025
English 106.4 KB
2025-09-17 16:00
RESULTS OF A MEETING HELD ON AUGUEST 6, 2025
English 36.3 KB
2025-09-08 16:00
to Present Research at the Single Cell Genomics 2025 Conference
English 94.0 KB

Automate Your Workflow. Get a real-time feed of all Compugen Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Compugen Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Compugen Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Avalo Therapeutics, Inc. Logo
Clinical-stage biotech developing treatments for immune-mediated inflammatory diseases.
United States of America
AVTX
Azenta, Inc. Logo
Offers sample management, storage, and multiomics solutions for life sciences.
United States of America
AZTA
BenevolentAI Logo
Applies artificial intelligence to accelerate drug discovery and development.
United Kingdom
BAI
bioAffinity Technologies, Inc. Logo
Develops noninvasive diagnostics and targeted therapeutics for cancer.
United States of America
BIAF
BioArctic Logo
Biopharmaceutical firm developing antibody therapies for neurodegenerative diseases.
Sweden
BIOA
BioInfra Co.,Ltd. Logo
Develops multi-biomarker blood tests for early cancer screening and gene treatments.
South Korea
199730
BioInfra Life Science Inc. Logo
Develops multi-biomarker blood tests for early cancer screening and gene treatments.
South Korea
266470
BioNexus Gene Lab Corp Logo
Develops gene-based diagnostics for early detection of disease susceptibility.
United States of America
BGLC
Biophytis S.A. Logo
Clinical-stage biotech developing therapeutics for age-related degenerative diseases.
France
ALBPS
BioRestorative Therapies, Inc. Logo
Develops adult stem cell therapies for degenerative disc and metabolic disorders.
United States of America
BRTX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.